Results 51 to 60 of about 1,726,301 (219)

The efficacy and safety of entecavir in patients with chronic hepatitis B- associated liver failure: a meta-analysis

open access: yesAnnals of Hepatology, 2015
Background. The effectiveness of nucleoside analogue (NA) treatment in patients with chronic hepatitis B (CHB) -associated liver failure is still controversial.
Xiaoguo Zhang   +6 more
doaj   +1 more source

Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study

open access: yesInfectious Diseases and Therapy, 2020
Objectives This study aimed to observe the efficacy of corticosteroids in non-severe COVID-19 pneumonia. Methods A retrospective study based on propensity score matching was designed to explore the effects of corticosteroids.
Qiang Li   +8 more
doaj   +1 more source

Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma

open access: yesBMC Medical Genomics, 2021
Background Although the effects of macrophages and CD8 T cell infiltration on clinical outcome have been widely reported, the association between immunity-associated gene with them for hepatocellular carcinoma (HCC) remains unclear. Materials and methods
Junyu Huo, Liqun Wu, Yunjin Zang
doaj   +1 more source

Clinical study of hepatitis B vaccine in achieving hepatitis B surface antibody seroconversion in patients with functional cure

open access: yesBrazilian Journal of Infectious Diseases, 2023
Hepatitis B Surface Antigen (HBsAg) seroclearance is the highest treatment goal recommended by the current guidelines for hepatitis B. Levels of antibodies to HBsAg (anti-HBs) are strongly associated with HBsAg recurrence, but hepatitis B vaccination may
Yisi Liu   +9 more
doaj   +1 more source

The Role of Ursodeoxycholic Acid Administration During the COVID-19 Pandemic: A Questionnaire Survey

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology
In December 2022, China classified COVID-19 as a category B infectious disease. This ended 2 years of close epidemiological surveillance of COVID-19. The objective of this questionnaire was to assess the infection status in the COVID-19 pandemic since ...
Cheng Zhou   +6 more
doaj   +1 more source

Obesity-Associated Nonalcoholic Fatty Liver Disease

open access: yes, 2014
Obesity is strongly associated with the prevalence of nonalcoholic fatty liver disease (NAFLD) in adult and pediatric populations. Nutrition, physical activity, and behavioral modifications are critical components of the treatment regimen for all obese ...
YILMAZ, YUSUF
core   +1 more source

Epidemiology of Alcohol-associated Liver Disease

open access: yes, 2021
Alcohol-associated liver disease (ALD) is a consequence of excessive alcohol use. It comprises a spectrum of histopathologic changes ranging from simple steatosis, steatohepatitis, and cirrhosis to hepatocellular carcinoma.
Han, Sen   +5 more
core   +1 more source

ncRNA-mediated SOX4 overexpression correlates with unfavorable outcomes and immune infiltration in hepatocellular carcinoma

open access: yesBMC Gastroenterology
Background The activity and number of immune cells in the tumor microenvironment are closely related to the overall survival of patients with hepatocellular carcinoma (HCC).
Jing Li   +10 more
doaj   +1 more source

Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B

open access: yesInternational Journal of Infectious Diseases, 2016
Objectives: Few studies have investigated serum levels of platelet-derived growth factor (PDGF) in patients with chronic hepatitis B (CHB). The present study aimed to determine whether PDGF-BB could serve as a potential biomarker for the detection of ...
Jiyuan Zhou   +4 more
doaj   +1 more source

Liver physiology and liver diseases in the elderly

open access: yesWorld Journal of Gastroenterology, 2013
The liver experiences various changes with aging that could affect clinical characteristics and outcomes in patients with liver diseases. Both liver volume and blood flow decrease significantly with age. These changes and decreased cytochrome P450 activity can affect drug metabolism, increasing susceptibility to drug-induced liver injury.
Kazuto, Tajiri, Yukihiro, Shimizu
openaire   +2 more sources

Home - About - Disclaimer - Privacy